Jim Cramer flew through his take on caller favorite stocks, including this semiconductor play.
Experts say a "grand bargain" between President-elect Trump and Russia's leader could be negotiated.
As the Dow inches toward the 20,000-point milestone, analysts give predictions on sectors poised for growth in 2017.
At the National Competitiveness Forum, CNBC's Sara Eisen speaks with Christopher Crane, Exelon CEO, about recent energy and environmental policies and what a Trump administration could do for the industry.
Jim Cramer quickly provided his opinion on various stocks, including this one that left a sour taste from cutting the dividend.
Jim Cramer broke down his thoughts on the election’s impact on stocks and how investors should adjust their portfolios.
Christopher Crane, Exelon President CEO, discusses the future for his company's nuclear power plants.
Lots of ETFs are on the dividend yield bandwagon, but only one claims it can predict which stocks will boost payouts.
The "Fast Money" traders pick whether they'd rather own a company's stock or bond for the next 30 years.
CNBC's Dominic Chu reports on where to find buying opportunities as bond yields are near record lows.
Jim Cramer is concerned about Disney and says there’s reason you should be too even if you don’t own the stock.
Great Plains Energy, the parent of regulated utility Kansas City Power & Light, said it would buy rival Westar Energy for $8.6 billion.
Hiring was expected to have continued at a strong pace in April, even as the economy grows at a sluggish pace.
Interest rates have been moving up recently and that could spell trouble for investors in Utility ETFs.
Some of the names on the move ahead of the open.
U.S. stock futures were higher, heading into the final four trading days of March and the first quarter.
CNBC's Morgan Brennan looks at the utilities sector as a safe haven even as the stocks get pricey.
Dan Eggers, Credit Suisse, explains how to approach the utilities space and shares four stock picks he likes.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Jefferies saying Therapeutics MD will double.
Jim Cramer reveals what is really going on with Harley-Davidson lately, along with other caller favorite stocks.